High-risk groups | Unweighted proportion of the sample, % (95% CI) | Weighted proportion of the population, % (95% CI) | Proportion recommended statin in 2012 guidelines, % | Weighted proportion recommended statin, % | Weighted proportion at risk and on a statin, % (95% CI) | Weighted proportion at risk not on a statin, % (95% CI) | Number sub-optimally treated, N (95% CI) |
---|---|---|---|---|---|---|---|
Known CVD | 4.9 (4.1 to 5.6) | 5.3 (4.4 to 6.3) | 100 | 5.3 | 3.7 (2.9 to 4.5) | 1.6 (1.0 to 2.1) | 11 715 (7856 to 15 574) |
Known diabetes | 4.2 (3.5 to 4.8) | 4.3 (3.6 to 5.0) | 100 | 4.3 | 2.5 (1.9 to 3.0) | 1.8 (1.3 to 2.3) | 13 398 (9767 to 17 030) |
SCORE ≥5% | 4.2 (3.5 to 4.8) | 4.9 (3.9 to 5.8) | 87* | 4.3 | 0.7 (0.4 to 1.1) | 3.6 (2.8 to 4.4) | 26 772 (20 889 to 32 655) |
Total | 51 885 |
*Statin recommendation is based on LDL-C bands in 2012 guidelines, 87% of those with SCORE ≥5% in the study sample fulfilled the criteria for statin therapy according to the guidelines.
Census 2011, total number 50–64 years in population=737 694.18
2012 Guidelines.3
CVD, cardiovascular disease; LDL-C, low-density lipoprotein cholesterol; SCORE, Systematic COronary Risk Evaluation; TILDA, The Irish Longitudinal Study on Ageing.